Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 341 - 360 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »
Reset  ↻

Ventyx Biosciences Announces Pipeline Updates and Highlights Strategic Priorities at Investor R&D Day

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Ventyx Biosciences, Inc.

PDS Biotech Announces Participation in the Channelchek Takeaway Series

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  PDS Biotechnology Corporation

Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Nemaura Medical Inc.

Elixirgen Therapeutics Enters Memorandum of Understanding with Hitachi Global Life Solutions for the Development of Micro GMP Suites for Cell Therapy Administration

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Elixirgen Therapeutics, Inc. | Elixirgen Scientific, Inc. | Elixirgen Scientific, Inc.

ProSomnus® Announces Acceptance of Abstract for Oral Presentation at Prestigious American Thoracic Society 2023 International Conference

Read more ››
By: GlobenewsWire - 26 Jan 2023

Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Previously Completed Phase 3 Trial of DCCR for Treatment of Prader-Willi Syndrome

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Soleno Therapeutics, Inc.

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Nautilus Biotechnology Inc.

Cocrystal Pharma Announces Participation in Virtual Investor Events

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Cocrystal Pharma, Inc.

Veru to Report Fiscal 2023 First Quarter Financial Results on February 9, 2023

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Veru Inc.

Sight Sciences Announces 1,000th TearCare® Customer Installation

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Sight Sciences, Inc.

Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Artelo Biosciences, Inc.

Panbela Announces Pricing of Approximately $15 Million Public Offering

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Panbela Therapeutics, Inc.

LAPIX Therapeutics Inc. Announces a Successful Conclusion of its Pre-IND Meeting Request with the U.S. FDA

Read more ››
By: GlobenewsWire - 26 Jan 2023

Centessa Pharmaceuticals Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of LB101, First LockBody® Candidate, for Solid Tumors

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Centessa Pharmaceuticals Limited

Brain Scientific Partners with SysteMedic, Receives First Purchase Order for NeuroCaps in Israel

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Brain Scientific Inc.

IRADIMED CORPORATION to Hold 2022 Fourth Quarter Financial Results Conference Call on February 2nd

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  iRadimed Corporation

PFC USA Renews HFMA Peer Review Designation

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Fordham Financial Management, Inc. | Boston Financial Management, LLC

Acerus Files For CCAA Protection

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Acerus Pharmaceuticals Corporation

Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  Psycheceutical Bioscience, Inc.

BioAegis Therapeutics Announces FDA Clearance of IND for its ‘Inflammation Regulator Protein,’ Gelsolin, for the Treatment of ARDS

Read more ››
By: GlobenewsWire - 26 Jan 2023
Related companies:  BioAegis Therapeutics Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »
Terms of Use & Privacy Policy
to the top ↑
{literal} {/literal}